Hester Biosciences
1,843.20
+28.70(+1.58%)
Market Cap₹1,543.60 Cr
PE Ratio55.40
IndustryHealthcare
Company Performance:
1D+1.58%
1M-0.63%
6M-12.03%
1Y-40.54%
5Y+39.21%
View Company Insightsright
Latest news about Hester Biosciences
Hester Biosciences Declares Dividend Amidst Q4 Profit Decline May 09, 2025
Hester Biosciences announced a ₹7 per share dividend despite a 73.74% drop in Q4 consolidated net profit to ₹13 million. Revenue increased by 4.05% to ₹72 crore, while sales decreased by 5.67%. EBITDA rose 11.29%, but operating profit halved. The company reported a significant increase in other income to ₹8.80 crore, potentially offsetting operational challenges.